IRIS Archives

Information and Referral and Internet Sightings

IRIS@LISTSERV.ICORS.ORG

Options: Use Forum View

Use Monospaced Font
Show Text Part by Default
Show All Mail Headers

Message: [<< First] [< Prev] [Next >] [Last >>]
Topic: [<< First] [< Prev] [Next >] [Last >>]
Author: [<< First] [< Prev] [Next >] [Last >>]

Print Reply
Subject:
From:
Sylvia Caras <[log in to unmask]>
Reply To:
Date:
Mon, 22 Jun 2009 10:06:52 -0700
Content-Type:
text/plain
Parts/Attachments:
text/plain (16 lines)
i3 Explores Link Between Bipolar Disorder and Lipid Disorder
 From PharmaLive News Archive - Jun 18, 2009
BASKING RIDGE, NJ, June 18, 2009­Pharmaceutical 
services company i3 announced today that i3 
Research will present seven posters at the 49th 
Annual New Clinical Drug Evaluation Unit meeting, 
a critical venue for psychopharmacology, to be 
held June 29-July 2 in Hollywood, FL.

(Freely associating - lipid disorder, fats, 
weight gain, new antipsychotics which can cause 
metabolic disorder, ... .  Sylvia)


"People Who experience mood swings, fear, voices and visions"

ATOM RSS1 RSS2